Martin Rifkin, MD
Urology · Gainesville, FLNPI 1639128168
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Teleflex LLC at 43.6% of the total. Reporting peaked in 2022 at $782 and has fallen 93.8% since, to $48 in 2025. That places this record below the midpoint for urology clinicians in FL, where the typical reported total is $3,881.
Across 27 payments — averaging $60.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$707
- Medtronic$463
- Pfizer$131
- Johnson & Johnson$77
- Endo Pharmaceuticals Inc.$65
- Axonics, Inc.$63
- plus $117 from 6 others
Across 4 payments — averaging $234,375 each. An ownership or investment interest held by the physician or an immediate family member.
- Novapproach Spine, LLC$938K
What the payments were for
- Travel & lodging$74246%
- Food & beverage$85353%
- Education$272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 7 | $707 |
| Medtronic | 4 | $463 |
| Pfizer | 3 | $131 |
| Johnson & Johnson | 1 | $77 |
| Endo Pharmaceuticals Inc. | 4 | $65 |
| Axonics, Inc. | 1 | $63 |
| Tempus AI, Inc | 1 | $28 |
| Astellas Pharma US Inc | 2 | $23 |
| Boston Scientific | 1 | $21 |
| Procept Biorobotics Corporation | 1 | $17 |
| Rochester Medical Corporation | 1 | $16 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,623 in reported general payments places this provider in the 30th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 110 | $72,969 |
| GemtesaVibegron | 42 | $37,762 |
| Tamsulosin Hcl | 739 | $11,506 |
| Potassium Citrate ErPotassium Citrate | 64 | $7,110 |
| Finasteride | 411 | $5,839 |
| Solifenacin Succinate | 52 | $2,716 |
| Estradiol | 31 | $2,377 |
| Testosterone | 32 | $2,179 |
| Trospium Chloride | 23 | $1,656 |
| Oxybutynin Chloride ErOxybutynin Chloride | 90 | $1,652 |
| Tadalafil | 22 | $1,521 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 84 | $1,500 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 49 | $1,451 |
| Silodosin | 16 | $1,264 |
| Testosterone Cypionate | 19 | $988 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $23 | $72,969110 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 935 urology providers in Florida.
Other urology in Gainesville
- Christopher WestGainesville$246K
- Lawrence YeungGainesville$68K
- Paul PeritoCoral Gables$3.6M
- Scott SellingerTallahassee$2.3M
- Mark Anthony GonzalgoMiami$1M
- Edward GheilerHialeah$655K
- Rolando RiveraNaples$437K
- Matthew ErcolaniVenice$416K
- Olubayo TojuolaOrlando$283K
- Juan SuarezCoral Gables$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.